Genomics and Personalized Medicine (Q2)
joint with the meeting on The Cancer Genome (Q1)


Scientific Organizers: Michael Snyder, Leroy E. Hood and Heidi L. Rehm


February 7—11, 2016

Fairmont Banff Springs, Banff, Alberta, Canada


Supported by the Directors' Fund


Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.


Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
Scholarship Deadline: Oct 7, 2015 [details]
Discounted Abstract Deadline: Oct 7, 2015 [details]
Abstract Deadline: Nov 9, 2015 [details]
Discounted Registration Deadline: Dec 7, 2015 [details]


Submit an Abstract Register Yourself Deadlines and Fees

Apply for a Scholarship



No registration fees are used to fund entertainment or alcohol at this conference


Conference Program Print | View meeting in 12 hr (am/pm) time

The meeting will begin on Sunday, February 7 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, February 11 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, February 12 in order to fully experience the meeting.

SUNDAY, FEBRUARY 7





16:00—20:00

Arrival and Registration







18:00—20:00

Welcome Mixer

No registration fees are used to fund alcohol served at this function.





MONDAY, FEBRUARY 8





07:00—08:00

Breakfast







08:00—09:30

Welcome and Keynote Session: Cancer Genomics in the Clinic (Joint)

Registered attendees can view abstracts starting on 01/07/2016

Discuss the current state of cancer medicine as it relates to genomics-based typing to determine targeted therapy response. Evaluate the challenges remaining from the standpoint of medical practice, and results to-date from programs in different countries.






Levi A. Garraway†, Dana-Farber Cancer Institute, USA
Sequencing and Clinical Interpretation to Guide Precision Cancer Medicine



Eric Schadt, Mount Sinai School of Medicine, USA
Advances in Human Genome Analyses




09:30—09:50

Coffee Break







09:50—11:45

Cancer Genomics: Discovery to Translation (Joint)

Registered attendees can view abstracts starting on 01/07/2016






Speakers to be Announced



Elaine R. Mardis, Washington University, USA
Clinical Translation of Cancer Genomics



Short Talk(s) Chosen from Abstracts




11:45—13:00

Poster Setup







13:00—22:00

Poster Viewing









On Own for Lunch







14:30—16:30

Panel: Challenges of Precision Oncology in the Clinical Setting







Levi A. Garraway†, Dana-Farber Cancer Institute, USA



Lillian Siu†, Princess Margaret Hospital, Canada



Charles Swanton†, London Research Institute, UK




16:30—17:00

Coffee Available







17:00—19:00

Disease Gene Discovery

Registered attendees can view abstracts starting on 01/07/2016






Speaker to be Announced



Richard P. Lifton†, HHMI/Yale University School of Medicine, USA
Advances in Cardiovascular Disease Genetics



Richard A. Gibbs, Baylor College of Medicine, USA
Discovering the Basis of Mendelian Disease



Short Talk Chosen from Abstracts





Following Session is for The Cancer Genome (Q1)




17:00—19:00

Genome-Guided Cancer Therapy

Registered attendees can view abstracts starting on 01/07/2016






Lillian Siu, Princess Margaret Hospital, Canada
Experience from Princess Margaret IMPACT/COMPACT Trial



Charles Swanton†, London Research Institute, UK
TraceRX Clinical Trial Progress at CRUK



Mariam Jamal-Hanjani, University College London, UK
Talk Title to be Announced



Short Talk Chosen from Abstracts




19:00—20:00

Social Hour with Lite Bites

No registration fees are used to fund alcohol served at this function.






19:30—22:00

Poster Session 1






TUESDAY, FEBRUARY 9





07:00—08:00

Breakfast







08:00—11:00

Technology and Sensors

Registered attendees can view abstracts starting on 01/07/2016






Speaker to be Announced



Rob Knight†, University of California, San Diego, USA
Personal Microbiome



Jim R. Heath, California Institute of Technology, USA
Affinity Reagents and Sensors



Steve Quake†, Stanford University, USA
Cool Technologies



Short Talk(s) Chosen from Abstracts





Following Session is for The Cancer Genome (Q1)




08:00—11:00

Genomics Informs Personalized Immunotherapy

Registered attendees can view abstracts starting on 01/07/2016






Robert D. Schreiber, Washington University School of Medicine, USA
Genomic Approaches to Understand Cancer Immunosuppression



Speaker to be Announced



James P. Allison†, University of Texas MD Anderson Cancer Center, USA
Blockade Therapies: Current Experience and Future Directions



Speaker to be Announced



Short Talk(s) Chosen from Abstracts




09:20—09:40

Coffee Break







11:00—13:00

Poster Setup







13:00—22:00

Poster Viewing









On Own for Lunch







16:30—17:00

Coffee Available







17:00—19:00

Personal Medicine and Health (Joint)

Registered attendees can view abstracts starting on 01/07/2016






Leroy E. Hood, Institute for Systems Biology, USA
Talk Title to be Announced



David Solit†, Memorial Sloan Kettering Cancer Center, USA
Talk Title to be Announced



Heidi Rehm, Harvard Medical School, USA
Supporting Genomic Interpretation



Short Talk Chosen from Abstracts




19:00—20:00

Social Hour with Lite Bites

No registration fees are used to fund alcohol served at this function.






19:30—22:00

Poster Session 2






WEDNESDAY, FEBRUARY 10





07:00—08:00

Breakfast







08:00—11:00

Personalized and Preventative Medicine

Registered attendees can view abstracts starting on 01/07/2016






Geoffrey S. Ginsburg, Duke University, USA
Novel Paradigms for Early Disease Detection



Michael Snyder, Stanford University School of Medicine, USA
Personal Omics Profiing



David R. Walt, Tufts University, USA
Single Molecule Arrays for Ultrasensitive Multiplexed Measurements of Proteins and Nucleic Acids



Jim Kaput, Nestlé Institute of Health Sciences, Switzerland
Nutrition



Short Talk(s) Chosen from Abstracts





Following Session is for The Cancer Genome (Q1)




08:00—11:00

Emerging Themes in Cancer Genomics

Registered attendees can view abstracts starting on 01/07/2016






Arul M. Chinnaiyan, University of Michigan, USA
Molecular Tumor Board at UMichigan: Progress and Impact



Jeff Tyner, Oregon Health & Science University, USA
Combining Genomic and Functional Screening in Targeted Therapy Decision-Making



Speaker to be Announced



Marco A. Marra, British Columbia Cancer Agency, Canada
Report from the Personal Oncology Genome Sequencing (POGS) Program at BCCA



Short Talk(s) Chosen from Abstracts